Magnesium and Procysbi drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium (magnesium) and Procysbi (cysteamine bitartrate). Common drug interactions include renal transplant among females and weight increased among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium and Procysbi. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium?

Magnesium has active ingredients of magnesium. It is often used in constipation. eHealthMe is studying from 121,147 Magnesium users. Check the latest studies of Magnesium.

What is Procysbi?

Procysbi has active ingredients of cysteamine bitartrate. eHealthMe is studying from 998 Procysbi users. Check the latest studies of Procysbi.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

42 people who take Magnesium and Procysbi together, and have interactions are studied.

Magnesium and Procysbi drug interactions.

What are the common drug interactions of Magnesium and Procysbi, by gender? *:

female:

Renal transplant
Vomiting
Eye pruritus (eye itching)
Diarrhoea
Epigastric discomfort
Hypersensitivity
Abdominal pain upper
Blood pressure increased
Cough
Decreased immune responsiveness

male:

Weight increased
Contusion (a type of hematoma of tissue in which capillaries)
Erythema (redness of the skin)
Rash papular (redness with papule)
Diabetes mellitus inadequate control
Eye pain
Headache (pain in head)
Hospitalisation

What are the common drug interactions of Magnesium and Procysbi, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Renal transplant
Contusion (a type of hematoma of tissue in which capillaries)
Erythema (redness of the skin)
Hypersensitivity
Rash papular (redness with papule)

10-19:

Eye pain
Headache (pain in head)
Hospitalisation

20-29:

Decreased immune responsiveness
Heart rate increased
Inflammation
Oropharyngeal pain
Pyrexia (fever)
Renal transplant
Sinusitis (inflammation of sinus)
White blood cell count decreased
Abdominal discomfort
Burning sensation

30-39:

Nausea (feeling of having an urge to vomit)
Abdominal discomfort
Vomiting
Diarrhoea
Epigastric discomfort

40-49:

n/a

50-59:

n/a

60+:

Diabetes mellitus inadequate control

What are the existing conditions these people have? *

Cystinosis (abnormal accumulation of the amino acid cystine): 32 people, 76.19%
Amino Acid Metabolism Disorder: 8 people, 19.05%
High Blood Pressure: 7 people, 16.67%
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins): 5 people, 11.90%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 11.90%
Stress And Anxiety: 3 people, 7.14%
Post-Traumatic Stress Disorder: 3 people, 7.14%
Migraine (headache): 3 people, 7.14%
Electrolyte Imbalance: 3 people, 7.14%
Depression: 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium and Procysbi?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously